Skip to main content
. 2023 Jan 23;2023(1):CD008986. doi: 10.1002/14651858.CD008986.pub4

2.4. Analysis.

2.4

Comparison 2: Secondary outcomes ‐ Trials comparing medication reviews with standard care, Outcome 4: Hospital readmissions (due to drug‐related adverse events)